Bone Loss Prevention in ovariectomized rats using stable amorphous calcium carbonate

Galit Shaltiel, Elad Bar-David, Oren E Meiron, Eitan Waltman, Assaf Shechter, Eliahu D Aflalo, David Stepensky, Amir Berman, Berdine R Martin, Connie M Weaver, Amir Sagi

Research output: Contribution to journalArticlepeer-review


In assessing the relationship between calcium supplementation and maintaining bone mass or reducing the risk of fracture, the effectiveness of calcium supplementation has never been decisive. Freshwater crayfish rely on amorphous calcium carbonate (ACC), an instable polymorph of calcium carbonate, as the main mineral in the exoskeleton and in the temporary storage organ, the gastrolith. Inspired by the crayfish model, we have previously shown an increase in calcium bioavailability in rats administered with synthetic stable ACC vs. crystalline calcium carbonate (CCC). The current study compared the effects of amorphous calcium derived from either gastrolith or synthetic ACC with those of crystalline calcium, found in commercial CCC or calciumcitrate supplements, in a bone loss prevention model. Rats were subjected to either sham or ovariectomy (OVX) operation (n~20/ group) followed by administration of food pellets supplemented with 0.5% calcium from either source over 12 weeks. Micro-computed tomography (μCT) and histomorphometric analyses revealed bone loss prevention by both gastrolith and ACC treatments, manifested by an increase in morphometric bone parameters, compared to both CCC- and calcium citrate-treated groups. Both gastrolith and ACC treatments resulted in bone formation in the tibia cancellous bone, indicated by dynamic histomorphometry parameters, compared to either the CCC or calcium citrate treatments. Levels of urine deoxypyridinoline (DPD), suggested an anti-resorptive effect of ACC, which was also the only treatment that led to a significant increase in vertebral mechanical strength, as supported by μCT analysis of topology and orientation parameters of the vertebral trabeculae. To our knowledge, such levels of bone loss prevention by calcium supplements have never been reported. These findings thus suggest the potential of both natural (crayfish gastrolith) and, to a greater extent, synthetic ACC sources for the prevention of metabolic bone disorders and possibly of osteoporotic processes.
Original languageEnglish
Pages (from-to)18-29
Number of pages12
Issue number7B
StatePublished - 2013


  • amorphous calcium carbonate
  • Calcium Citrate
  • Bone Metabolism
  • Ovariectomized Rats
  • Gastrolith
  • Osteoporosis


Dive into the research topics of 'Bone Loss Prevention in ovariectomized rats using stable amorphous calcium carbonate'. Together they form a unique fingerprint.

Cite this